Back to search

National and Kapodistrian University of Athens

Ανοστοϊστοχημική εκτίμηση πρωτεϊνών οξείας φάσης σε διηθητικά καρκινώματα μαστού

Abstract

dc:description

Purpose: The purpose of the present study relates to the value of the Hsp70/90 expression in breast cancer patients. An important assumption that could stem from this study is the potential of these molecules as treatment-targets in the medical armamentarium against breast cancer.Methods: In order to evaluate the potential value of Hsp70/90 expression, an original study with tissue samples from 54 patients with ductal carcinomas of the breast was undertaken. Immunohistochemical staining was performed in order to evaluate the level of Hsp70/90 expression in the various tissues, as well as the expression of ER, PR, HER2 and Ki67, in the same samples. The difference in expression of these molecules in the continuum of ductal breast cancer neoplasia, histological grade, tumor size, the presence of lymph node and distant metastases was also examined. Furthermore, a systematic review of the current bibliography was performed to evaluate the effect of Hsp70/90 expression in patients’ survival, PCNALI and the variables examined in the original study of this paper. Additionally a quantitative synthesis (meta-analysis) of the relevant variables, of the included studies, was performed.Results: As far as the results of the original study are concerned, no statistically significant correlation could be established. The only exception is the significantly lower expression of Hsp90 in IDC (Invasive Ductal Carcinoma) compared to that in DCIS (Ductal Carcinoma in Situ) (DCIS (6.54±1.31 vs. 7.16±0.82, respectively, p=0.004, Wilcoxon matched-pairs signed-ranks test), and is, in turn, lower in DCIS than NBT (Normal Breast Tissue) (p=0.0002, same test). Regarding the systematic review, the only two points where the literature unanimously concurs are the positive association between Hsp70 expression and PCNALI and the significantly worse overall survival of patients with high Hsp90 expression. According to the meta-analysis performed, high Hsp90 expression was associated with worse overall survival and marginally with worse disease free survival. High Hsp70 expression was also correlated with worse disease free survival, as well as with ER positivity and PR positivity.Conclusion: This systematic review and meta-analysis highlights the prognostic role of Hsp90 and Hsp70 expression in breast cancer. Further high-quality studies, with detailed reporting are needed to provide epidemiological evidence complementing the findings of ongoing clinical trials on Hsp inhibitors.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2018

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Dimas, Dionysios
  • Δήμας, Διονύσιος

Subjects

dc:subject × 10

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/43283

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Dimas, Dionysios; Δήμας, Διονύσιος. Ανοστοϊστοχημική εκτίμηση πρωτεϊνών οξείας φάσης σε διηθητικά καρκινώματα μαστού. National and Kapodistrian University of Athens, 2018. http://hdl.handle.net/10442/hedi/43283